|
|
|
|
| LEADER |
03655cam a22004817i 4500 |
| 001 |
MUB03000000686 |
| 003 |
CZ BrMU |
| 005 |
20230803082836.0 |
| 008 |
160930t20022002xxu|||||o|||||||||||eng d |
| STA |
|
|
|a EIZ
|b 36
|c Kluwer/Springer trvale nakupy
|d 2016-09-30
|
| 020 |
|
|
|a 0-306-48143-X
|q (eBook)
|z 978-0-306-48143-7
|
| 035 |
|
|
|a (DE-He213)978-0-306-48143-7
|
| 040 |
|
|
|a DE-He213
|b cze
|e rda
|d BOD002
|
| 072 |
|
7 |
|a 616
|x Patologie. Klinická medicína
|2 Konspekt
|9 14
|
| 080 |
|
|
|a 616.65-006.04
|2 MRF
|
| 245 |
0 |
0 |
|a Prostate cancer :
|b new horizons in research and treatment /
|c edited by Michael L. Cher, Avraham Raz, Kenneth V. Honn
|
| 264 |
|
1 |
|a New York :
|b Kluwer Academic Publishers,
|c [2002]
|
| 264 |
|
4 |
|c ©2002
|
| 300 |
|
|
|a 1 online zdroj (399 stran) :
|b ilustrace
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a počítač
|b c
|2 rdamedia
|
| 338 |
|
|
|a online zdroj
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Developments in oncology ;
|v 81
|
| 505 |
0 |
|
|a Pathology of prostate cancer -- Prostate cancer susceptibility genes: Many studies, many results, no answers -- Molecular profiling in prostate cancer -- Chromosomal deletions and tumor suppressor genes in prostate cancer -- Role of eicosanoids in prostate cancer progression -- Contribution of the androgen receptor to prostate cancer predisposition and progression -- Regulation of apoptosis in prostate cancer -- On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis -- Metastasis suppression in prostate cancer -- The urokinase-type plasminogen activator system in prostate cancer metastasis -- Angiogenesis in prostate cancer: Biology and therapeutic opportunities -- Integrins and prostate cancer metastases -- Prostate carcinoma skeletal metastases: Cross-talk between tumor and bone -- Signal transduction targets in androgen-independent prostate cancer -- The diet, prostate inflammation, and the development of prostate cancer -- Prostate cancer diagnosis, staging and survival -- Surgery for prostate cancer: Rationale, technique and outcomes -- The future of cancer imaging -- Antisense therapy: Current status in prostate cancer and other malignancies -- Antiangiogenesis therapeutic strategies in prostate cancer -- Chemoprevention of prostate cancer -- Prostate brachytherapy -- Fast neutron irradiation for prostate cancer -- Prostate cancer gene therapy: Past experiences and future promise -- Vitamin D-related therapies in prostate cancer -- Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer.
|
| 533 |
|
|
|a Elektronická reprodukce.
|n Přístup pouze pro oprávněné uživatele
|
| 650 |
0 |
7 |
|a rakovina prostaty
|7 ph135009
|2 czenas
|
| 650 |
0 |
9 |
|a prostate cancer
|2 eczenas
|
| 655 |
|
7 |
|a e-knihy online
|2 CZ-BrMU
|
| 655 |
|
9 |
|a e-books online
|2 eCZ-BrMU
|
| 700 |
1 |
|
|a Cher, Michael L.
|4 edt
|
| 700 |
1 |
|
|a Raz, Avraham
|4 edt
|
| 700 |
1 |
|
|a Honn, Kenneth V.
|4 edt
|
| 776 |
0 |
8 |
|i Tištěná verze:
|t Prostate cancer : new horizons in research and treatment
|z 1-4020-7352-6
|
| 830 |
|
0 |
|a Developments in oncology ;
|v 81
|
| 856 |
4 |
1 |
|z Elektronická verze přístupná pouze pro studenty a pracovníky MU
|u http://dx.doi.org/10.1007/b101860
|
| CAT |
|
|
|c 20160930
|l MUB03
|h 1226
|
| CAT |
|
|
|c 20210421
|l MUB03
|h 2123
|
| CAT |
|
|
|c 20210421
|l MUB03
|h 2207
|
| CAT |
|
|
|a VASICEK
|b 02
|c 20230803
|l MUB03
|h 0828
|
| 995 |
|
|
|a eBook
|
| 994 |
- |
1 |
|l MUB03
|l MUB03
|m EBOOK
|1 KUK
|a Knihovna univ. kampusu
|2 EBKUK
|b e-knihy (trvalý nákup)
|5 3147L00083
|8 20111012
|f 83
|f Dálkově přístupná
|r 20111012
|s kup
|
| AVA |
|
|
|a MED50
|b KUK
|c e-knihy (trvalý nákup)
|e available
|t K dispozici
|f 1
|g 0
|h N
|i 0
|j EBKUK
|
